• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/21

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

21 Cards in this Set

  • Front
  • Back

Agonist

Stimulates and activates a receptor

Antagonist

Stops agonist from stimulating receptor

EC50

The concentration of drug that causes 50% of the maximal effect. It is a measure of drug POTENCY.




(50% Effective Concentration)

Emax

Efficacy Maximum, at which it is assumed all the receptors are occupied by the drug.


(At this point, higher concentrations of drug produce no effect)

Full Agonist

Can replicate the binding response of the body's physiological ligand

Partial Agonist

Unable to produce maximal effect, even if bound to all receptors.

Inverse Agonist

Stabilizes receptors in their inactive form

Antagonist

A ligand that can bind to a receptor and block or inactivate it, thus reducing agonist activity.

Competitive Antagonist

An antagonist that binds and prevents agonist from binding, inactivating the receptor.


- Shifts dose response curve of agonist to the RIGHT. (Because it takes a higher concentration of drug to get half of the Emax - lowered potency!)

Allosteric Antagonist


(Non-Competitive Antagonist)

Binds to a site on the receptor that is different than the agonist binding site, and causes a conformational change in the receptor, so the agonist can no longer bind. 

Binds to a site on the receptor that is different than the agonist binding site, and causes a conformational change in the receptor, so the agonist can no longer bind.

The ___________________ measures the relative safety of a drug, and gives a window of treatment.

The therapeutic index measures the relative safety of a drug, and gives a window of treatment.

How is the TI (therapeutic index) calculated?

The Toxic Dose in 50% of population, divided by the Effective Dose in 50% of the population.

The Toxic Dose in 50% of population, divided by the Effective Dose in 50% of the population.

PharmacoDynamics

The effect of the DRUG on your body.

Pharmacokinetics

The physiological response your body has to a drug.

KD

Binding Affinity


The concentration of drug required to bind 50% of the receptors.



Bmax

Binding Maximum


The total number of receptors.

Four Common Types of Receptors are:


1.


2.


3.


4.

Four Common Types of Receptors are:


1. Ionotropic (ie: ligand gated)


2. Metabotropic (ie: G-PCRs)


3. Kinase Linked (both a receptor & enzyme)


4. Steroid

Ligand

An agent that binds to a receptor

Spare Receptors

Receptors that are leftover (spare!) because maximal effect (Emax) has been reached without all the receptors being utilized.

With a constant blockade, a receptor may ______-regulate. This is usually by ______________ the number of receptors.

With a constant blockade, a receptor may up-regulate. This is usually by increasing the number of receptors.

With a constant stimulation, a receptor may ______-regulate. This is usually by ______________ the number of receptors.

With a constant stimulation, a receptor may down-regulate. This is usually by decreasing the number of receptors.